Key Insights

Highlights

Success Rate

94% trial completion (above average)

Published Results

148 trials with published results (26%)

Research Maturity

406 completed trials (71% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

4.2%

24 terminated out of 575 trials

Success Rate

94.4%

+7.8% vs benchmark

Late-Stage Pipeline

30%

174 trials in Phase 3/4

Results Transparency

36%

148 of 406 completed with results

Key Signals

148 with results94% success24 terminated

Data Visualizations

Phase Distribution

485Total
Not Applicable (235)
Early P 1 (5)
P 1 (23)
P 2 (48)
P 3 (76)
P 4 (98)

Trial Status

Completed406
Unknown76
Recruiting34
Terminated24
Withdrawn13
Not Yet Recruiting10

Trial Success Rate

94.4%

Benchmark: 86.6%

Based on 406 completed trials

Clinical Trials (575)

Showing 20 of 20 trials
NCT00001246Active Not RecruitingPrimary

Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Volunteers

NCT07640802Not Yet Recruiting

Psychotherapy for Irritability in Youth: Comparing Active Treatment to Nonactive Psychoeducation Supportive Psychotherapy

NCT05608434Phase 1RecruitingPrimary

Development of Virtual Reality-based Interventions to Strengthen Cognitive Skillsets Related to Attention Deficit Hyperactivity Disorder (ADHD): A Pilot Phase I and Randomized Controlled Phase II Trial

NCT07845981Not ApplicableNot Yet RecruitingPrimary

Multi-Component Training Versus Motor Learning Techniques in Adults With ADHD

NCT04631042Recruiting

Developing Brain, Impulsivity and Compulsivity

NCT06086951Not ApplicableCompleted

Pai.ACT - An Artificial Intelligence Driven Chatbot Assisted ACT

NCT07647900Not ApplicableActive Not RecruitingPrimary

Photography-Based Intervention for Children With Attention Deficit Hyperactivity Disorder

NCT07803224Not Yet RecruitingPrimary

Adult ADHD Symptoms, Depression, Anxiety, and Academic Performance in Medical Students

NCT04278404Recruiting

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

NCT05918991Not ApplicableActive Not RecruitingPrimary

Interventions for English Language Learners At-Risk for ADHD

NCT06406309Not ApplicableCompletedPrimary

Settling Down for Sleep in ADHD: The Impact of Sensory and Arousal Systems on Sleep in ADHD

NCT06194162Not ApplicableRecruiting

Weighted Blankets for Sleep Disturbance Among Children With ADHD

NCT04591951Not ApplicableCompletedPrimary

Family Navigation to Improve ADHD Treatment Adherence for Minority Children

NCT05872737Not ApplicableCompleted

FAB Programme for Parents of Children With NDD

NCT05467527Not ApplicableCompleted

PACT Programme for Parents of Children With SHCN

NCT07001475Phase 1Completed

A Study to Test How BI 3031185 is Tolerated by People With Borderline Personality Disorder or Attention-deficit/Hyperactivity Disorder

NCT07710014Phase 4Not Yet RecruitingPrimary

Evaluation of Foquest in Adults 65 Years and Older With ADHD

NCT06847165Not ApplicableRecruiting

Trigeminal Nerve Stimulation for Children With Prenatal Alcohol Exposure

NCT07678827Phase 3Not Yet RecruitingPrimary

A Phase 3 Study of Viloxazine ER Capsules in Korean Children and Adolescents With ADHD

NCT05631626Phase 3Completed

Phase 3 Efficacy and Safety Study in Adults With ADHD Using CTx-1301.

Scroll to load more

Research Network

Activity Timeline